Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

4.6
(226)
Write Review
More
$ 22.99
Add to Cart
In stock
Description

Avidity Biosciences: Revolutionizing RNA Therapeutics Field (NASDAQ:RNA)

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

AskBio Spins Out New Gene Therapy Company, Actus Therapeutics

AveXis Enters Agreement to be Acquired by Novartis AG for

Novus Therapeutics acquires Anelixis Therapeutics

Novus Therapeutics (@Novus_Thera) / X

Novus - Recent News & Activity

News & Events - Noble Capital Markets

Novus Acquisition of Anelixis